Literature DB >> 28262212

Type B Insulin Resistance in Peru.

Henry Zelada1, Dante Gamarra2, Hugo Arbañil2, Helard Manrique3.   

Abstract

Type B insulin resistance (IR) is a rare autoimmune disease characterized by the presence of insulin receptor autoantibodies, resulting in a marked IR inducing hyperglycemia. Our first case is a 42-year-old female with a history of RA, SLE and Hashimoto-thyroiditis that presented with cachexia, acanthosis-nigricans, hirsutism, negative anti-insulin-ab and glucose level between 400 to 700 mg/dl, despite a total insulin dose of 1000 IU/day. She received pulses of cyclophosphamide along with prednisone. One year later the patient was off insulin and with HbA1c of 5.6%. The second case is a 42-year-old female patient that presented with polyuria, polydipsia, cachexia, acanthosis-nigricans, negative glutamic-acid-decarboxilase-ab and positive TPO-ab. She received IV infusion of regular insulin at a rate of 500 UI/d. Two years later she was off insulin with HbA1C of 5.6%. As summary, we reported a case of a disease remitted after receiving immunosuppressive therapy and a case of disease remitted spontaneously.
Copyright © 2017 Southern Society for Clinical Investigation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Developing country; Immunosuppressive therapy; Insulin resistance; Latin America; Peru

Mesh:

Substances:

Year:  2016        PMID: 28262212     DOI: 10.1016/j.amjms.2016.07.001

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN: 0002-9629            Impact factor:   2.378


  2 in total

1.  Successful remission of type B insulin resistance syndrome without rituximab in an elderly male.

Authors:  Marcio José Concepción-Zavaleta; Sofía Pilar Ildefonso-Najarro; Esteban Alberto Plasencia-Dueñas; María Alejandra Quispe-Flores; Cristian David Armas-Flórez; Laura Esther Luna-Victorio
Journal:  Endocrinol Diabetes Metab Case Rep       Date:  2020-10-14

2.  Combined Immunosuppressive Therapy Induces Remission in Patients With Severe Type B Insulin Resistance: A Prospective Cohort Study.

Authors:  Joanna Klubo-Gwiezdzinska; Maria Lange; Elaine Cochran; Robert K Semple; Cornelia Gewert; Rebecca J Brown; Phillip Gorden
Journal:  Diabetes Care       Date:  2018-09-10       Impact factor: 19.112

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.